-
The Mold-Killing Machine For Weed That Would Survive The New Shark Tank Season
Thursday, November 28, 2024 - 11:00am | 1372XRPure's decontamination system offers a smart solution to microbial contamination that could save growers millions in lost revenue. XRPure's decontamination system offers a smart solution to microbial contamination that could save growers millions in lost revenue. This kind of efficiency is even...
-
Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing
Wednesday, January 3, 2024 - 11:04am | 559Clever Leaves Holdings Inc. (NASDAQ:CLVR), has been granted Australian GMP certification for its facilities in Colombia by the Therapeutic Goods Administration (TGA). The certification authorizes Clever Leaves to manufacture cannabis products for medical marijuana patients in Australia, the...
-
EXCLUSIVE: Expert Advice On How To Become Compliant Psychedelics Cultivator And Manufacturer
Friday, October 27, 2023 - 11:41am | 691What can businesses and clients expect from psychedelic-assisted therapies (PAT)? What are state regulations looking like from a for-profit perspective and what does it take to provide safe, effective and compliant treatments? Benzinga spoke with Kim Stuck, founder and CEO of Allay...
-
EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting
Thursday, October 26, 2023 - 4:31pm | 731What can businesses and clients expect of the incoming psychedelic-assisted therapies (PAT) scenario? What are state regulations looking like from a for-profit perspective, and what does it take to provide safe, effective and regulations-compliant treatments? Around these and other concerns,...
-
Building Australia's Psychedelics Industry: A New Joint Venture And Why It's Important
Friday, May 26, 2023 - 10:29am | 722On May 1, new partners Canadian psychedelics developer PharmAla Biotech and Australian digital healthcare business Vitura Health (formerly Cronos Australia) announced the definitive establishment of a 50-50 joint venture Cortexa. On May 20, the CEOs of both PharmAla and Vitura hosted a...
-
Revolutionizing Psychedelics: 2 Industry Leaders Collaborate To Offer Clinical-Grade MDMA Capsules
Tuesday, April 11, 2023 - 3:10pm | 415MDXX-class molecules producer PharmAla Biotech Holdings Inc. and natural psychedelics developer Filament Health Corp's (OTCQB: FLHLF) partnership is seeing the release of GMP-compliant MDMA capsules for distribution to clinical trials and authorized patients in Canada and worldwide....
-
Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK
Friday, January 20, 2023 - 6:39pm | 332Lifesciences psychedelics biotech Psyence Group Inc. (OTCQB: PSYGF) recently exported purified pharmaceutical-grade psilocybin mushroom extract from its licensed and certified production facility in Southern Africa to its Contract Development & Manufacturing Organization (CDMO) partner in...
-
PharmaCielo Achieves Colombian GMP Certification For Phytotherapeutics
Tuesday, September 14, 2021 - 2:14pm | 303PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) said Tuesday that it has received Colombian GMP Certification for Phytotherapeutics manufactured with its extracts and proprietary cultivars from the Colombian National Food and Drug Surveillance Institute. Bill Petron, CEO of the Toronto-based parent...